APO Research
Talk to an analyst

APO RESEARCH · REPORT

Microbiota Transplantation Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Microbiota Transplantation Service Market Analysis and Forecast 2026-2032

16 April 2026249 pages

Choose your research edition.

Industry ResearchMicrobiota Transplantation Service Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Microbiota Transplantation Service Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Microbiota Transplantation Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Microbiota Transplantation Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Microbiota Transplantation Service Market Analysis and Forecast 2026-2032249 pages · $4,950 USD

Market perspective

The global Microbiota Transplantation Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Microbiota Transplantation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Microbiota Transplantation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Microbiota Transplantation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Microbiota Transplantation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Microbiota Transplantation Service include Seres Therapeutics, Finch Therapeutics, OpenBiome, Vedanta Biosciences, MaaT Pharma, BiomX, Entera Health, Metabiomics and J-Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Microbiota Transplantation Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Microbiota Transplantation Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Microbiota Transplantation Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Microbiota Transplantation Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Microbiota Transplantation Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Microbiota Transplantation Service revenue, projected growth trends, production technology, application and end-user industry.

Microbiota Transplantation Service Segment by Company

Seres Therapeutics

Finch Therapeutics

OpenBiome

Vedanta Biosciences

MaaT Pharma

BiomX

Entera Health

Metabiomics

J-Pharma

Hangzhou Shengshi Technology

Ruiyi Biotechnology

Jiangsu Junkey Life Technology Development

Hangzhou Yuanxiang Medical Technology

MAUSOAR

Shanghai Chengge Biotechnology

Guangzhou Zhiyi Biotechnology

Shenzhen Unknown Jun Biotechnology

Sichuan Anaerobic Biotechnology

Microbiota Transplantation Service Segment by Type

Traditional Intestinal Transplantation

Oral Capsule Transplantation

Microbiota Transplantation Service Segment by Application

Medical Industry

Health Management Industry

Animal Health Industry

Others

Microbiota Transplantation Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microbiota Transplantation Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Microbiota Transplantation Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microbiota Transplantation Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Microbiota Transplantation Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Microbiota Transplantation Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Microbiota Transplantation Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Microbiota Transplantation Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Traditional Intestinal Transplantation Major Player Table 3. Oral Capsule Transplantation Major Player Table 4. Global Microbiota Transplantation Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Medical Industry Major Player Table 6. Health Management Industry Major Player Table 7. Animal Health Industry Major Player Table 8. Others Major Player Table 9. Microbiota Transplantation Service Industry Trends Table 10. Microbiota Transplantation Service Industry Drivers Table 11. Microbiota Transplantation Service Industry Opportunities and Challenges Table 12. Microbiota Transplantation Service Industry Restraints Table 13. Global Microbiota Transplantation Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Microbiota Transplantation Service Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Microbiota Transplantation Service Market Share by Region (2021-2026) Table 16. Global Microbiota Transplantation Service Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Microbiota Transplantation Service Market Share by Region (2027-2032) Table 18. Global Microbiota Transplantation Service Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Microbiota Transplantation Service Revenue Market Share by Players (2021-2026) Table 20. Global Microbiota Transplantation Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Microbiota Transplantation Service Key Players Headquarters & Area Served Table 22. Global Microbiota Transplantation Service Players, Product Type & Application Table 23. Global Microbiota Transplantation Service Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Microbiota Transplantation Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Microbiota Transplantation Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Microbiota Transplantation Service Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Microbiota Transplantation Service Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Microbiota Transplantation Service Revenue Market Share by Type (2021-2026) Table 30. Global Microbiota Transplantation Service Revenue Market Share by Type (2027-2032) Table 31. Global Microbiota Transplantation Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Microbiota Transplantation Service Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Microbiota Transplantation Service Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Microbiota Transplantation Service Revenue Market Share by Application (2021-2026) Table 35. Global Microbiota Transplantation Service Revenue Market Share by Application (2027-2032) Table 36. Seres Therapeutics Company Information Table 37. Seres Therapeutics Business Overview Table 38. Seres Therapeutics Microbiota Transplantation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Seres Therapeutics Microbiota Transplantation Service Product Portfolio Table 40. Seres Therapeutics Recent Development Table 41. Finch Therapeutics Company Information Table 42. Finch Therapeutics Business Overview Table 43. Finch Therapeutics Microbiota Transplantation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Finch Therapeutics Microbiota Transplantation Service Product Portfolio Table 45. Finch Therapeutics Recent Development Table 46. OpenBiome Company Information Table 47. OpenBiome Business Overview Table 48. OpenBiome Microbiota Transplantation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. OpenBiome Microbiota Transplantation Service Product Portfolio Table 50. OpenBiome Recent Development Table 51. Vedanta Biosciences Company Information Table 52. Vedanta Biosciences Business Overview Table 53. Vedanta Biosciences Microbiota Transplantation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Vedanta Biosciences Microbiota Transplantation Service Product Portfolio Table 55. Vedanta Biosciences Recent Development Table 56. MaaT Pharma Company Information Table 57. MaaT Pharma Business Overview Table 58. MaaT Pharma Microbiota Transplantation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. MaaT Pharma Microbiota Transplantation Service Product Portfolio Table 60. MaaT Pharma Recent Development Table 61. BiomX Company Information Table 62. BiomX Business Overview Table 63. BiomX Microbiota Transplantation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. BiomX Microbiota Transplantation Service Product Portfolio Table 65. BiomX Recent Development Table 66. Entera Health Company Information Table 67. Entera Health Business Overview Table 68. Entera Health Microbiota Transplantation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Entera Health Microbiota Transplantation Service Product Portfolio Table 70. Entera Health Recent Development Table 71. Metabiomics Company Information Table 72. Metabiomics Business Overview Table 73. Metabiomics Microbiota Transplantation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Metabiomics Microbiota Transplantation Service Product Portfolio Table 75. Metabiomics Recent Development Table 76. J-Pharma Company Information Table 77. J-Pharma Business Overview Table 78. J-Pharma Microbiota Transplantation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. J-Pharma Microbiota Transplantation Service Product Portfolio Table 80. J-Pharma Recent Development Table 81. Hangzhou Shengshi Technology Company Information Table 82. Hangzhou Shengshi Technology Business Overview Table 83. Hangzhou Shengshi Technology Microbiota Transplantation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Hangzhou Shengshi Technology Microbiota Transplantation Service Product Portfolio Table 85. Hangzhou Shengshi Technology Recent Development Table 86. Ruiyi Biotechnology Company Information Table 87. Ruiyi Biotechnology Business Overview Table 88. Ruiyi Biotechnology Microbiota Transplantation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Ruiyi Biotechnology Microbiota Transplantation Service Product Portfolio Table 90. Ruiyi Biotechnology Recent Development Table 91. Jiangsu Junkey Life Technology Development Company Information Table 92. Jiangsu Junkey Life Technology Development Business Overview Table 93. Jiangsu Junkey Life Technology Development Microbiota Transplantation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Jiangsu Junkey Life Technology Development Microbiota Transplantation Service Product Portfolio Table 95. Jiangsu Junkey Life Technology Development Recent Development Table 96. Hangzhou Yuanxiang Medical Technology Company Information Table 97. Hangzhou Yuanxiang Medical Technology Business Overview Table 98. Hangzhou Yuanxiang Medical Technology Microbiota Transplantation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Hangzhou Yuanxiang Medical Technology Microbiota Transplantation Service Product Portfolio Table 100. Hangzhou Yuanxiang Medical Technology Recent Development Table 101. MAUSOAR Company Information Table 102. MAUSOAR Business Overview Table 103. MAUSOAR Microbiota Transplantation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. MAUSOAR Microbiota Transplantation Service Product Portfolio Table 105. MAUSOAR Recent Development Table 106. Shanghai Chengge Biotechnology Company Information Table 107. Shanghai Chengge Biotechnology Business Overview Table 108. Shanghai Chengge Biotechnology Microbiota Transplantation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Shanghai Chengge Biotechnology Microbiota Transplantation Service Product Portfolio Table 110. Shanghai Chengge Biotechnology Recent Development Table 111. Guangzhou Zhiyi Biotechnology Company Information Table 112. Guangzhou Zhiyi Biotechnology Business Overview Table 113. Guangzhou Zhiyi Biotechnology Microbiota Transplantation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Guangzhou Zhiyi Biotechnology Microbiota Transplantation Service Product Portfolio Table 115. Guangzhou Zhiyi Biotechnology Recent Development Table 116. Shenzhen Unknown Jun Biotechnology Company Information Table 117. Shenzhen Unknown Jun Biotechnology Business Overview Table 118. Shenzhen Unknown Jun Biotechnology Microbiota Transplantation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Shenzhen Unknown Jun Biotechnology Microbiota Transplantation Service Product Portfolio Table 120. Shenzhen Unknown Jun Biotechnology Recent Development Table 121. Sichuan Anaerobic Biotechnology Company Information Table 122. Sichuan Anaerobic Biotechnology Business Overview Table 123. Sichuan Anaerobic Biotechnology Microbiota Transplantation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Sichuan Anaerobic Biotechnology Microbiota Transplantation Service Product Portfolio Table 125. Sichuan Anaerobic Biotechnology Recent Development Table 126. North America Microbiota Transplantation Service Revenue by Type (2021-2026) & (US$ Million) Table 127. North America Microbiota Transplantation Service Revenue by Type (2027-2032) & (US$ Million) Table 128. North America Microbiota Transplantation Service Revenue by Application (2021-2026) & (US$ Million) Table 129. North America Microbiota Transplantation Service Revenue by Application (2027-2032) & (US$ Million) Table 130. North America Microbiota Transplantation Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. North America Microbiota Transplantation Service Revenue by Country (2021-2026) & (US$ Million) Table 132. North America Microbiota Transplantation Service Revenue by Country (US$ Million) & (2027-2032) Table 133. Europe Microbiota Transplantation Service Revenue by Type (2021-2026) & (US$ Million) Table 134. Europe Microbiota Transplantation Service Revenue by Type (2027-2032) & (US$ Million) Table 135. Europe Microbiota Transplantation Service Revenue by Application (2021-2026) & (US$ Million) Table 136. Europe Microbiota Transplantation Service Revenue by Application (2027-2032) & (US$ Million) Table 137. Europe Microbiota Transplantation Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Europe Microbiota Transplantation Service Revenue by Country (2021-2026) & (US$ Million) Table 139. Europe Microbiota Transplantation Service Revenue by Country (US$ Million) & (2027-2032) Table 140. China Microbiota Transplantation Service Revenue by Type (2021-2026) & (US$ Million) Table 141. China Microbiota Transplantation Service Revenue by Type (2027-2032) & (US$ Million) Table 142. China Microbiota Transplantation Service Revenue by Application (2021-2026) & (US$ Million) Table 143. China Microbiota Transplantation Service Revenue by Application (2027-2032) & (US$ Million) Table 144. Asia Microbiota Transplantation Service Revenue by Type (2021-2026) & (US$ Million) Table 145. Asia Microbiota Transplantation Service Revenue by Type (2027-2032) & (US$ Million) Table 146. Asia Microbiota Transplantation Service Revenue by Application (2021-2026) & (US$ Million) Table 147. Asia Microbiota Transplantation Service Revenue by Application (2027-2032) & (US$ Million) Table 148. Asia Microbiota Transplantation Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Asia Microbiota Transplantation Service Revenue by Region (US$ Million) & (2021-2026) Table 150. Asia Microbiota Transplantation Service Revenue by Region (US$ Million) & (2027-2032) Table 151. SAMEA Microbiota Transplantation Service Revenue by Type (2021-2026) & (US$ Million) Table 152. SAMEA Microbiota Transplantation Service Revenue by Type (2027-2032) & (US$ Million) Table 153. SAMEA Microbiota Transplantation Service Revenue by Application (2021-2026) & (US$ Million) Table 154. SAMEA Microbiota Transplantation Service Revenue by Application (2027-2032) & (US$ Million) Table 155. SAMEA Microbiota Transplantation Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. SAMEA Microbiota Transplantation Service Revenue by Country (2021-2026) & (US$ Million) Table 157. SAMEA Microbiota Transplantation Service Revenue by Country (US$ Million) & (2027-2032) Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources Table 161. Primary Sources List of Figures Figure 1. Microbiota Transplantation Service Image Figure 2. Global Microbiota Transplantation Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Microbiota Transplantation Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Traditional Intestinal Transplantation Image Figure 5. Oral Capsule Transplantation Image Figure 6. Global Microbiota Transplantation Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Microbiota Transplantation Service Market Size Share 2021 VS 2025 VS 2032 Figure 8. Medical Industry Image Figure 9. Health Management Industry Image Figure 10. Animal Health Industry Image Figure 11. Others Image Figure 12. Global Microbiota Transplantation Service Market Size (US$ Million) & (2021-2032) Figure 13. Global Microbiota Transplantation Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Microbiota Transplantation Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Microbiota Transplantation Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Microbiota Transplantation Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Microbiota Transplantation Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Microbiota Transplantation Service Revenue Market Share by Type (2021-2032) Figure 20. Global Microbiota Transplantation Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Microbiota Transplantation Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Microbiota Transplantation Service Revenue Market Share by Application (2021-2032) Figure 23. North America Microbiota Transplantation Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Microbiota Transplantation Service Revenue Share by Type (2021-2032) Figure 25. North America Microbiota Transplantation Service Revenue Share by Application (2021-2032) Figure 26. North America Microbiota Transplantation Service Revenue Share by Country (2021-2032) Figure 27. United States Microbiota Transplantation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Microbiota Transplantation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Microbiota Transplantation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Microbiota Transplantation Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Microbiota Transplantation Service Revenue Share by Type (2021-2032) Figure 32. Europe Microbiota Transplantation Service Revenue Share by Application (2021-2032) Figure 33. Europe Microbiota Transplantation Service Revenue Share by Country (2021-2032) Figure 34. Germany Microbiota Transplantation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Microbiota Transplantation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Microbiota Transplantation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Microbiota Transplantation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Microbiota Transplantation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Microbiota Transplantation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Microbiota Transplantation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Microbiota Transplantation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Microbiota Transplantation Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Microbiota Transplantation Service Revenue Share by Type (2021-2032) Figure 44. China Microbiota Transplantation Service Revenue Share by Application (2021-2032) Figure 45. Asia Microbiota Transplantation Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Microbiota Transplantation Service Revenue Share by Type (2021-2032) Figure 47. Asia Microbiota Transplantation Service Revenue Share by Application (2021-2032) Figure 48. Asia Microbiota Transplantation Service Revenue Share by Region (2021-2032) Figure 49. Japan Microbiota Transplantation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Microbiota Transplantation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Microbiota Transplantation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Microbiota Transplantation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Microbiota Transplantation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Microbiota Transplantation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Microbiota Transplantation Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Microbiota Transplantation Service Revenue Share by Type (2021-2032) Figure 57. SAMEA Microbiota Transplantation Service Revenue Share by Application (2021-2032) Figure 58. SAMEA Microbiota Transplantation Service Revenue Share by Country (2021-2032) Figure 59. Brazil Microbiota Transplantation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Microbiota Transplantation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Microbiota Transplantation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Microbiota Transplantation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Microbiota Transplantation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Microbiota Transplantation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Microbiota Transplantation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Microbiota Transplantation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Microbiota Transplantation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Microbiota Transplantation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Microbiota Transplantation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Traditional Intestinal Transplantation
  • Oral Capsule Transplantation
Applications
  • Medical Industry
  • Health Management Industry
  • Animal Health Industry
  • Others
Companies covered
  • Seres Therapeutics
  • Finch Therapeutics
  • OpenBiome
  • Vedanta Biosciences
  • MaaT Pharma
  • BiomX
  • Entera Health
  • Metabiomics
  • J-Pharma
  • Hangzhou Shengshi Technology
  • Ruiyi Biotechnology
  • Jiangsu Junkey Life Technology Development
  • Hangzhou Yuanxiang Medical Technology
  • MAUSOAR
  • Shanghai Chengge Biotechnology
  • Guangzhou Zhiyi Biotechnology
  • Shenzhen Unknown Jun Biotechnology
  • Sichuan Anaerobic Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Microbiota Transplantation Service Market by Type
  3. 1.2.1 Global Microbiota Transplantation Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Traditional Intestinal Transplantation
  5. 1.2.3 Oral Capsule Transplantation
  6. 1.3 Microbiota Transplantation Service Market by Application
  7. 1.3.1 Global Microbiota Transplantation Service Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Medical Industry
  9. 1.3.3 Health Management Industry
  10. 1.3.4 Animal Health Industry
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Microbiota Transplantation Service Market Dynamics
  1. 2.1 Microbiota Transplantation Service Industry Trends
  2. 2.2 Microbiota Transplantation Service Industry Drivers
  3. 2.3 Microbiota Transplantation Service Industry Opportunities and Challenges
  4. 2.4 Microbiota Transplantation Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Microbiota Transplantation Service Market Perspective (2021-2032)
  2. 3.2 Global Microbiota Transplantation Service Growth Trends by Region
  3. 3.2.1 Global Microbiota Transplantation Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Microbiota Transplantation Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Microbiota Transplantation Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Microbiota Transplantation Service Revenue by Players
  2. 4.1.1 Global Microbiota Transplantation Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Microbiota Transplantation Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Microbiota Transplantation Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Microbiota Transplantation Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Microbiota Transplantation Service Key Players Headquarters & Area Served
  7. 4.4 Global Microbiota Transplantation Service Players, Product Type & Application
  8. 4.5 Global Microbiota Transplantation Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Microbiota Transplantation Service Market CR5 and HHI
  11. 4.6.3 2025 Microbiota Transplantation Service Tier 1, Tier 2, and Tier 3
5 Microbiota Transplantation Service Market Size by Type
  1. 5.1 Global Microbiota Transplantation Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Microbiota Transplantation Service Revenue by Type (2021-2032)
  3. 5.3 Global Microbiota Transplantation Service Revenue Market Share by Type (2021-2032)
6 Microbiota Transplantation Service Market Size by Application
  1. 6.1 Global Microbiota Transplantation Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Microbiota Transplantation Service Revenue by Application (2021-2032)
  3. 6.3 Global Microbiota Transplantation Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Seres Therapeutics
  2. 7.1.1 Seres Therapeutics Company Information
  3. 7.1.2 Seres Therapeutics Business Overview
  4. 7.1.3 Seres Therapeutics Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Seres Therapeutics Microbiota Transplantation Service Product Portfolio
  6. 7.1.5 Seres Therapeutics Recent Developments
  7. 7.2 Finch Therapeutics
  8. 7.2.1 Finch Therapeutics Company Information
  9. 7.2.2 Finch Therapeutics Business Overview
  10. 7.2.3 Finch Therapeutics Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Finch Therapeutics Microbiota Transplantation Service Product Portfolio
  12. 7.2.5 Finch Therapeutics Recent Developments
  13. 7.3 OpenBiome
  14. 7.3.1 OpenBiome Company Information
  15. 7.3.2 OpenBiome Business Overview
  16. 7.3.3 OpenBiome Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 OpenBiome Microbiota Transplantation Service Product Portfolio
  18. 7.3.5 OpenBiome Recent Developments
  19. 7.4 Vedanta Biosciences
  20. 7.4.1 Vedanta Biosciences Company Information
  21. 7.4.2 Vedanta Biosciences Business Overview
  22. 7.4.3 Vedanta Biosciences Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Vedanta Biosciences Microbiota Transplantation Service Product Portfolio
  24. 7.4.5 Vedanta Biosciences Recent Developments
  25. 7.5 MaaT Pharma
  26. 7.5.1 MaaT Pharma Company Information
  27. 7.5.2 MaaT Pharma Business Overview
  28. 7.5.3 MaaT Pharma Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 MaaT Pharma Microbiota Transplantation Service Product Portfolio
  30. 7.5.5 MaaT Pharma Recent Developments
  31. 7.6 BiomX
  32. 7.6.1 BiomX Company Information
  33. 7.6.2 BiomX Business Overview
  34. 7.6.3 BiomX Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 BiomX Microbiota Transplantation Service Product Portfolio
  36. 7.6.5 BiomX Recent Developments
  37. 7.7 Entera Health
  38. 7.7.1 Entera Health Company Information
  39. 7.7.2 Entera Health Business Overview
  40. 7.7.3 Entera Health Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Entera Health Microbiota Transplantation Service Product Portfolio
  42. 7.7.5 Entera Health Recent Developments
  43. 7.8 Metabiomics
  44. 7.8.1 Metabiomics Company Information
  45. 7.8.2 Metabiomics Business Overview
  46. 7.8.3 Metabiomics Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Metabiomics Microbiota Transplantation Service Product Portfolio
  48. 7.8.5 Metabiomics Recent Developments
  49. 7.9 J-Pharma
  50. 7.9.1 J-Pharma Company Information
  51. 7.9.2 J-Pharma Business Overview
  52. 7.9.3 J-Pharma Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 J-Pharma Microbiota Transplantation Service Product Portfolio
  54. 7.9.5 J-Pharma Recent Developments
  55. 7.10 Hangzhou Shengshi Technology
  56. 7.10.1 Hangzhou Shengshi Technology Company Information
  57. 7.10.2 Hangzhou Shengshi Technology Business Overview
  58. 7.10.3 Hangzhou Shengshi Technology Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Hangzhou Shengshi Technology Microbiota Transplantation Service Product Portfolio
  60. 7.10.5 Hangzhou Shengshi Technology Recent Developments
  61. 7.11 Ruiyi Biotechnology
  62. 7.11.1 Ruiyi Biotechnology Company Information
  63. 7.11.2 Ruiyi Biotechnology Business Overview
  64. 7.11.3 Ruiyi Biotechnology Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Ruiyi Biotechnology Microbiota Transplantation Service Product Portfolio
  66. 7.11.5 Ruiyi Biotechnology Recent Developments
  67. 7.12 Jiangsu Junkey Life Technology Development
  68. 7.12.1 Jiangsu Junkey Life Technology Development Company Information
  69. 7.12.2 Jiangsu Junkey Life Technology Development Business Overview
  70. 7.12.3 Jiangsu Junkey Life Technology Development Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Jiangsu Junkey Life Technology Development Microbiota Transplantation Service Product Portfolio
  72. 7.12.5 Jiangsu Junkey Life Technology Development Recent Developments
  73. 7.13 Hangzhou Yuanxiang Medical Technology
  74. 7.13.1 Hangzhou Yuanxiang Medical Technology Company Information
  75. 7.13.2 Hangzhou Yuanxiang Medical Technology Business Overview
  76. 7.13.3 Hangzhou Yuanxiang Medical Technology Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Hangzhou Yuanxiang Medical Technology Microbiota Transplantation Service Product Portfolio
  78. 7.13.5 Hangzhou Yuanxiang Medical Technology Recent Developments
  79. 7.14 MAUSOAR
  80. 7.14.1 MAUSOAR Company Information
  81. 7.14.2 MAUSOAR Business Overview
  82. 7.14.3 MAUSOAR Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 MAUSOAR Microbiota Transplantation Service Product Portfolio
  84. 7.14.5 MAUSOAR Recent Developments
  85. 7.15 Shanghai Chengge Biotechnology
  86. 7.15.1 Shanghai Chengge Biotechnology Company Information
  87. 7.15.2 Shanghai Chengge Biotechnology Business Overview
  88. 7.15.3 Shanghai Chengge Biotechnology Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Shanghai Chengge Biotechnology Microbiota Transplantation Service Product Portfolio
  90. 7.15.5 Shanghai Chengge Biotechnology Recent Developments
  91. 7.16 Guangzhou Zhiyi Biotechnology
  92. 7.16.1 Guangzhou Zhiyi Biotechnology Company Information
  93. 7.16.2 Guangzhou Zhiyi Biotechnology Business Overview
  94. 7.16.3 Guangzhou Zhiyi Biotechnology Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Guangzhou Zhiyi Biotechnology Microbiota Transplantation Service Product Portfolio
  96. 7.16.5 Guangzhou Zhiyi Biotechnology Recent Developments
  97. 7.17 Shenzhen Unknown Jun Biotechnology
  98. 7.17.1 Shenzhen Unknown Jun Biotechnology Company Information
  99. 7.17.2 Shenzhen Unknown Jun Biotechnology Business Overview
  100. 7.17.3 Shenzhen Unknown Jun Biotechnology Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Shenzhen Unknown Jun Biotechnology Microbiota Transplantation Service Product Portfolio
  102. 7.17.5 Shenzhen Unknown Jun Biotechnology Recent Developments
  103. 7.18 Sichuan Anaerobic Biotechnology
  104. 7.18.1 Sichuan Anaerobic Biotechnology Company Information
  105. 7.18.2 Sichuan Anaerobic Biotechnology Business Overview
  106. 7.18.3 Sichuan Anaerobic Biotechnology Microbiota Transplantation Service Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Sichuan Anaerobic Biotechnology Microbiota Transplantation Service Product Portfolio
  108. 7.18.5 Sichuan Anaerobic Biotechnology Recent Developments
8 North America
  1. 8.1 North America Microbiota Transplantation Service Revenue (2021-2032)
  2. 8.2 North America Microbiota Transplantation Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Microbiota Transplantation Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Microbiota Transplantation Service Revenue by Type (2027-2032)
  5. 8.3 North America Microbiota Transplantation Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Microbiota Transplantation Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Microbiota Transplantation Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Microbiota Transplantation Service Revenue by Application (2027-2032)
  9. 8.5 North America Microbiota Transplantation Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Microbiota Transplantation Service Revenue by Country
  11. 8.6.1 North America Microbiota Transplantation Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Microbiota Transplantation Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Microbiota Transplantation Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Microbiota Transplantation Service Revenue (2021-2032)
  2. 9.2 Europe Microbiota Transplantation Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Microbiota Transplantation Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Microbiota Transplantation Service Revenue by Type (2027-2032)
  5. 9.3 Europe Microbiota Transplantation Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Microbiota Transplantation Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Microbiota Transplantation Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Microbiota Transplantation Service Revenue by Application (2027-2032)
  9. 9.5 Europe Microbiota Transplantation Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Microbiota Transplantation Service Revenue by Country
  11. 9.6.1 Europe Microbiota Transplantation Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Microbiota Transplantation Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Microbiota Transplantation Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Microbiota Transplantation Service Revenue (2021-2032)
  2. 10.2 China Microbiota Transplantation Service Revenue by Type (2021-2032)
  3. 10.2.1 China Microbiota Transplantation Service Revenue by Type (2021-2026)
  4. 10.2.2 China Microbiota Transplantation Service Revenue by Type (2027-2032)
  5. 10.3 China Microbiota Transplantation Service Revenue Share by Type (2021-2032)
  6. 10.4 China Microbiota Transplantation Service Revenue by Application (2021-2032)
  7. 10.4.1 China Microbiota Transplantation Service Revenue by Application (2021-2026)
  8. 10.4.2 China Microbiota Transplantation Service Revenue by Application (2027-2032)
  9. 10.5 China Microbiota Transplantation Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Microbiota Transplantation Service Revenue (2021-2032)
  2. 11.2 Asia Microbiota Transplantation Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Microbiota Transplantation Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Microbiota Transplantation Service Revenue by Type (2027-2032)
  5. 11.3 Asia Microbiota Transplantation Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Microbiota Transplantation Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Microbiota Transplantation Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Microbiota Transplantation Service Revenue by Application (2027-2032)
  9. 11.5 Asia Microbiota Transplantation Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Microbiota Transplantation Service Revenue by Country
  11. 11.6.1 Asia Microbiota Transplantation Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Microbiota Transplantation Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Microbiota Transplantation Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Microbiota Transplantation Service Revenue (2021-2032)
  2. 12.2 SAMEA Microbiota Transplantation Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Microbiota Transplantation Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Microbiota Transplantation Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Microbiota Transplantation Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Microbiota Transplantation Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Microbiota Transplantation Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Microbiota Transplantation Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Microbiota Transplantation Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Microbiota Transplantation Service Revenue by Country
  11. 12.6.1 SAMEA Microbiota Transplantation Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Microbiota Transplantation Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Microbiota Transplantation Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst